# Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy

> **NCT00955942** · PHASE1 · TERMINATED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 48 (actual)

## Conditions studied

- Lung Cancer
- Radiation Toxicity

## Interventions

- **DIETARY_SUPPLEMENT:** flaxseed
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00955942
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-12
- **Primary completion:** 2012-07
- **Final completion:** 2018-06
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Insufficient enrollment
- **Last updated:** 2020-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955942, "Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00955942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*